Buscar
Balchem Corp
BCPCAñadir a la lista de seguimiento
168.800USD
-0.090-0.05%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
5.42BCap. mercado
34.32P/E TTM
Más Datos de Balchem Corp Compañía
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Información de Balchem Corp
Símbolo de cotizaciónBCPC
Nombre de la empresaBalchem Corp
Fecha de salida a bolsaJun 03, 1986
Director ejecutivoHarris (Theodore L)
Número de empleados1361
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 03
Dirección- -
Ciudad- -
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Símbolo de cotizaciónBCPC
Fecha de salida a bolsaJun 03, 1986
Director ejecutivoHarris (Theodore L)
Ejecutivos de Balchem Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
74.51K
+0.97%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
7.45K
+8.59%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
5.08K
+19.25%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
4.08K
+34.87%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
980.00
+11.22%
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
980.00
+11.22%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. Daniel E. Knutson, CPA
Mr. Daniel E. Knutson, CPA
Independent Director
Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Kathleen B. Fish
Ms. Kathleen B. Fish
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
74.51K
+0.97%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
7.45K
+8.59%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
5.08K
+19.25%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
4.08K
+34.87%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
980.00
+11.22%
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
980.00
+11.22%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Balchem Corp?
Los cinco principales accionistas de Balchem Corp son: Mr. Theodore L. (Ted) Harris
¿Cuántas instituciones poseen acciones de Balchem Corp (BCPC)?
A fecha de 2026Q1, 741 instituciones poseen acciones de Balchem Corp, con un valor de mercado combinado de aproximadamente 28.38M, lo que representa el 88.34% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -2011669.00.
¿Cuál es la mayor fuente de ganancias de Balchem Corp?
El 2026Q1, el segmento empresarial Product Sales Revenue generó la ganancia más alta para Balchem Corp, ascendiendo a 1.04B y representando el 99.82% de la ganancia total.